Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1985-12-24
|
pubmed:abstractText |
This study was undertaken to compare intravenous gamma-globulin (IVGG) for 1 year in patients with primary immune defects who had previously been treated with intramuscular gamma-globulin (IMGG). Forty-three patients were available for analysis. After administration of 300 mg/kg of IVGG every 3 weeks, blood immunoglobulin levels increased to within 1 SD of normal for the patient's ages. In 5 patients, this dosage regimen did not raise the immunoglobulin levels satisfactorily, although they were still better than those achieved with IMGG. In 18 patients, treatment benefits became apparent after 5 - 6 months of treatment. Substantial improvement was observed in 70% of these patients. Sixteen reactions occurred with 638 infusions, an incidence rate of 2.5%. If 2 patients with an IgM macroglobulin and 1 patient with an anti-IgA antibody were excluded, the reaction incidence would probably have been 1%.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-9007
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
8-14
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2416128-Follow-Up Studies,
pubmed-meshheading:2416128-Humans,
pubmed-meshheading:2416128-Immune Sera,
pubmed-meshheading:2416128-Immunization, Passive,
pubmed-meshheading:2416128-Immunologic Deficiency Syndromes,
pubmed-meshheading:2416128-Infusions, Parenteral,
pubmed-meshheading:2416128-gamma-Globulins
|
pubmed:year |
1985
|
pubmed:articleTitle |
Intravenous immune serum globulin in immunodeficiency.
|
pubmed:publicationType |
Journal Article
|